Cargando…
Down syndrome: the aggravation of COVID-19 may be partially justified by the expression of TMPRSS2
Autores principales: | Evangelho, Victor Gustavo Oliveira, Bello, Murilo Lamim, Castro, Helena Carla, Amorim, Marcia Rodrigues |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8579173/ https://www.ncbi.nlm.nih.gov/pubmed/34757552 http://dx.doi.org/10.1007/s10072-021-05715-z |
Ejemplares similares
-
Type 2 inflammation modulates ACE2 and TMPRSS2 in airway epithelial cells
por: Kimura, Hiroki, et al.
Publicado: (2020) -
COVID-19 in patients with Down syndrome
por: Emami, Amir, et al.
Publicado: (2021) -
Sound prescriptions to mitigate the effects of COVID-19 in the population with Down syndrome
por: Verd, Sergio, et al.
Publicado: (2021) -
COVID-19 infection and Down syndrome—challenges and future directions for care in children
por: Chauhan, Kaushambi, et al.
Publicado: (2022) -
Locking down the CGRP pathway during the COVID-19 pandemic lockdown: the PandeMig study
por: Altamura, Claudia, et al.
Publicado: (2020)